SE8502525D0 - 1,3-oxazolidine-2-one derivatives and processes for their preparation - Google Patents

1,3-oxazolidine-2-one derivatives and processes for their preparation

Info

Publication number: SE8502525D0
Authority: SE; Sweden
Prior art keywords: oxazolidine; derivatives; processes; preparation; medicinal
Prior art date: 1984-09-28

Application number

SE8502525A

Other languages

English (en)

Other versions

SE463100B (sv

SE8502525L (sv

Inventor

M Masaki

H Shinozaki

M Satoh

N Moritoh

K Hashimoto

T Kamishiro

Original Assignee

Nippon Chemiphar Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-09-28

Filing date

1985-05-22

Publication date

1985-05-22

1985-05-22 Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co

1985-05-22 Publication of SE8502525D0 publication Critical patent/SE8502525D0/sv

1986-03-29 Publication of SE8502525L publication Critical patent/SE8502525L/sv

1990-10-08 Publication of SE463100B publication Critical patent/SE463100B/sv

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

SE8502525A 1984-09-28 1985-05-22 1,3-oxazolidin-2-on-derivat och foerfaranden foer framstaellning daerav SE463100B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP59203624A JPS6183170A (ja)	1984-09-28	1984-09-28	新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法

Publications (3)

Publication Number	Publication Date
SE8502525D0 true SE8502525D0 (sv)	1985-05-22
SE8502525L SE8502525L (sv)	1986-03-29
SE463100B SE463100B (sv)	1990-10-08

Family

ID=16477122

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8502525A SE463100B (sv)	1984-09-28	1985-05-22	1,3-oxazolidin-2-on-derivat och foerfaranden foer framstaellning daerav

Country Status (27)

Country	Link
US (1)	US4644063A (sv)
JP (1)	JPS6183170A (sv)
KR (1)	KR900004323B1 (sv)
AR (1)	AR240924A1 (sv)
AT (1)	AT392069B (sv)
AU (1)	AU566419B2 (sv)
BR (1)	BR8502707A (sv)
CA (1)	CA1252092A (sv)
CH (1)	CH663207A5 (sv)
CS (1)	CS273606B2 (sv)
DE (1)	DE3519261C2 (sv)
DK (1)	DK165952C (sv)
ES (2)	ES8800571A1 (sv)
FR (1)	FR2571052B1 (sv)
GB (2)	GB8512975D0 (sv)
HU (1)	HU199132B (sv)
IN (1)	IN162060B (sv)
IT (1)	IT1208807B (sv)
MX (2)	MX161397A (sv)
MY (1)	MY102081A (sv)
NL (1)	NL193191C (sv)
NZ (1)	NZ212143A (sv)
PH (1)	PH20852A (sv)
RO (1)	RO91422B (sv)
SE (1)	SE463100B (sv)
SU (2)	SU1402263A3 (sv)
ZA (1)	ZA854001B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6183147A (ja) *	1984-09-28	1986-04-26	Nippon Chemiphar Co Ltd	新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤
JPH0759570B2 (ja) *	1986-05-06	1995-06-28	三井東圧化学株式会社	２−オキサゾリジノン類の製造方法
JPH0713017B2 (ja) *	1986-06-18	1995-02-15	日本ケミファ株式会社	脳細胞保護作用を有する医薬組成物
ES2053748T3 (es) *	1987-09-10	1994-08-01	Merck Sharp & Dohme	Oxazoles y tiazoles para el tratamiento de la demencia senil.
CA1329128C (en) *	1988-03-24	1994-05-03	Nobuyoshi Iwata	Isoxazolinones as cerebro-active drugs
JPH0314562A (ja) *	1988-04-11	1991-01-23	Nippon Chemiphar Co Ltd	新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
US5187171A (en) *	1989-01-09	1993-02-16	G. D. Searle & Co.	Use of a glycine b partial agonist as an antipsychotic
ES2121036T3 (es) *	1992-07-14	1998-11-16	Nippon Chemiphar Co	Derivados de alquilenodiamina.
US5698573A (en) *	1993-09-15	1997-12-16	Merck, Sharp & Dohme, Ltd.	Imidazolone and oxazolone derivatives as dopamine antagonists
DE4425613A1 (de) *	1994-07-20	1996-01-25	Bayer Ag	5-gliedrige Heteroaryl-oxazolidinone
US6037354A (en)	1997-06-18	2000-03-14	Merck & Co., Inc.	Alpha 1a adrenergic receptor antagonists
AU2014230940B2 (en)	2013-03-14	2016-12-08	Akzo Nobel Chemicals International B.V.	Cellulose ether as a drift control agent and rainfastness agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2437389A (en) *		1948-03-09		Oxazoeidones and erocesstok
DE1135461B (de) *	1959-05-08	1962-08-30	Knoll Ag	Verfahren zur Herstellung von basisch substituierten Phthalimidinen
FR1301267A (fr) *	1961-04-04	1962-08-17	Science Union Et Compagnie Soc	Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation
US3131197A (en) *	1963-03-13	1964-04-28	Smith Kline French Lab	5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone
US3576808A (en) *	1967-09-15	1971-04-27	Miles Lab	N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
GB1222708A (en) *	1968-10-22	1971-02-17	Delalande Sa	Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
FR2179582B1 (sv) *	1972-04-13	1975-10-10	Synthelabo

1984
- 1984-09-28 JP JP59203624A patent/JPS6183170A/ja active Granted
1985
- 1985-05-21 NZ NZ212143A patent/NZ212143A/en unknown
- 1985-05-22 GB GB858512975A patent/GB8512975D0/en active Pending
- 1985-05-22 SE SE8502525A patent/SE463100B/sv not_active IP Right Cessation
- 1985-05-23 DK DK230185A patent/DK165952C/da not_active IP Right Cessation
- 1985-05-23 IN IN382/MAS/85A patent/IN162060B/en unknown
- 1985-05-24 DE DE3519261A patent/DE3519261C2/de not_active Expired - Fee Related
- 1985-05-24 PH PH32310A patent/PH20852A/en unknown
- 1985-05-27 ES ES543517A patent/ES8800571A1/es not_active Expired
- 1985-05-27 ZA ZA854001A patent/ZA854001B/xx unknown
- 1985-05-28 CA CA000482506A patent/CA1252092A/en not_active Expired
- 1985-05-29 KR KR1019850003726A patent/KR900004323B1/ko not_active IP Right Cessation
- 1985-05-29 US US06/739,059 patent/US4644063A/en not_active Expired - Lifetime
- 1985-05-30 SU SU853902250A patent/SU1402263A3/ru active
- 1985-05-30 FR FR8508128A patent/FR2571052B1/fr not_active Expired
- 1985-05-30 GB GB08513685A patent/GB2165237B/en not_active Expired
- 1985-05-30 HU HU852082A patent/HU199132B/hu not_active IP Right Cessation
- 1985-05-30 IT IT8567500A patent/IT1208807B/it active
- 1985-05-30 RO RO118984A patent/RO91422B/ro unknown
- 1985-05-31 BR BR8502707A patent/BR8502707A/pt not_active IP Right Cessation
- 1985-05-31 MX MX205493A patent/MX161397A/es unknown
- 1985-05-31 CH CH2317/85A patent/CH663207A5/fr not_active IP Right Cessation
- 1985-05-31 NL NL8501579A patent/NL193191C/nl not_active IP Right Cessation
- 1985-05-31 CS CS392785A patent/CS273606B2/cs unknown
- 1985-05-31 AT AT0165685A patent/AT392069B/de not_active IP Right Cessation
- 1985-05-31 AR AR300604A patent/AR240924A1/es active
- 1985-07-09 AU AU44697/85A patent/AU566419B2/en not_active Ceased
1986
- 1986-05-13 SU SU864027452A patent/SU1431679A3/ru active
- 1986-09-18 ES ES557075A patent/ES8802152A1/es not_active Expired
1987
- 1987-09-29 MY MYPI87002215A patent/MY102081A/en unknown
1990
- 1990-07-16 MX MX2159290A patent/MX21592A/es unknown

Also Published As

Publication number	Publication date
GB8512975D0 (en)	1985-06-26
AU4469785A (en)	1986-04-10
AR240924A2 (es)	1991-03-27
ZA854001B (en)	1986-01-29
ES8802152A1 (es)	1988-04-01
IT1208807B (it)	1989-07-10
IN162060B (sv)	1988-03-19
HU199132B (en)	1990-01-29
AR240924A1 (es)	1991-03-27
KR900004323B1 (ko)	1990-06-22
NL193191B (nl)	1998-10-01
ES557075A0 (es)	1988-04-01
GB2165237A (en)	1986-04-09
NL8501579A (nl)	1986-04-16
ATA165685A (de)	1990-07-15
MY102081A (en)	1992-03-31
SU1402263A3 (ru)	1988-06-07
CA1252092A (en)	1989-04-04
DK165952B (da)	1993-02-15
PH20852A (en)	1987-05-19
ES8800571A1 (es)	1987-11-01
AU566419B2 (en)	1987-10-22
AT392069B (de)	1991-01-25
SU1431679A3 (ru)	1988-10-15
FR2571052B1 (fr)	1988-03-04
DK165952C (da)	1993-07-05
RO91422A (ro)	1987-06-30
BR8502707A (pt)	1986-05-27
FR2571052A1 (fr)	1986-04-04
GB2165237B (en)	1987-12-09
GB8513685D0 (en)	1985-07-03
SE463100B (sv)	1990-10-08
CS392785A2 (en)	1990-08-14
MX161397A (es)	1990-09-20
ES543517A0 (es)	1987-11-01
DK230185A (da)	1986-03-29
HUT39168A (en)	1986-08-28
NL193191C (nl)	1999-02-02
SE8502525L (sv)	1986-03-29
DE3519261A1 (de)	1986-04-10
DK230185D0 (da)	1985-05-23
KR860002502A (ko)	1986-04-26
US4644063A (en)	1987-02-17
MX21592A (es)	1994-01-31
RO91422B (ro)	1987-07-02
IT8567500A0 (it)	1985-05-30
JPH0469150B2 (sv)	1992-11-05
JPS6183170A (ja)	1986-04-26
NZ212143A (en)	1987-11-27
CH663207A5 (fr)	1987-11-30
DE3519261C2 (de)	1997-01-16
CS273606B2 (en)	1991-03-12

Publication	Publication Date	Title
ES509242A0 (es)	1983-03-16	"procedimiento para preparar nuevos compuestos de cefem".
SE8503922D0 (sv)	1985-08-22	Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
SE8601907L (sv)	1986-10-26	Antitrombogena och kardiotoniska imidazokinoliner
MX5680E (es)	1983-12-08	Procedimiento para la preparacion de 2-(2-alcoxietil)-2'-hidroxi-6,7-benzomorfanos
SE8804586D0 (sv)	1988-12-20	1,4-dihydro-4-oxonaftyridinderivat och salter daerav foerfarande foer framstaellning av dessa jaemte antibakteriella medel innefattande dessa
ATE25078T1 (de)	1987-02-15	2-amino-3-acylamino-6-benzylamino-pyridinderivate mit anti-epileptischer wirkung.
SE7714592L (sv)	1978-06-24	Cyklopentan-1-aminer, forfarande for framstellning derav och medel innehallande dessa foreningar
DE3669149D1 (de)	1990-04-05	Substituierte p,p'-methylen-bis-aniline.
SE8502525D0 (sv)	1985-05-22	1,3-oxazolidine-2-one derivatives and processes for their preparation
ES528452A0 (es)	1985-10-01	Procedimiento de preparacion de nuevos derivados dietilaminoalcoxibenzoles y de sus sales de adicion acidas y amonicas cuaternarias
DK178883A (da)	1983-04-22	2-(2'-hydroxy-3'-(1,1-dimethylpropylamino)-propoxy)-beta-phenylpropiophenon, syreadditionssalte deraf, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater med indhold deraf
SE8405123L (sv)	1984-10-12	Forfarande for framstellning av pyrrolidin- eller pyridinkarboxylsyraderivat
ES515872A0 (es)	1983-06-01	"procedimiento para la preparacion de nuevos derivados de acidos 4-fenoxialcarboxilicos sustituidos con radicales haterociclicos".
ZA871757B (en)	1987-09-01	1-phenylimidazolecarboxylic acid amides,their preparation and their use as growth regulators
ES510737A0 (es)	1983-02-01	"procedimiento para la preparacion de 1,1-dioxidos de 4-hidroxi-1,2-benzoisotiazol-3(2h)-ona"
DE3861545D1 (de)	1991-02-21	Aminoverbindungen und diese enthaltende fungizide.
ES515201A0 (es)	1983-11-01	"procedimiento para la fabricacion de derivados n- susbtituidos de la tetrahidroisftalimida".
JPS5427564A (en)	1979-03-01	1-branched alkylcarbonyl-3-(3,5-dihalogenophenyl) hydantoins, their preparation, and bactericides for pomicultural and horticultural uses containing the same as active agent.
DK601883A (da)	1984-06-29	Phenyl-propanolderivater
FI802651A (fi)	1981-02-23	2-(2-klor-4-cyklopropyl-fenyl-imino)-imidazolidin dess syraadditionssalter laekemedel innehaollande denna och foerfarande foer dess framstaellning
SE7908820L (sv)	1980-04-26	Imidazolyletoxiderivat av pyridin-5-metanoler och kinolin-3-metanoler

Legal Events

Date	Code	Title	Description
1995-01-31	NAL	Patent in force	Ref document number: 8502525-2 Format of ref document f/p: F
2001-01-22	NUG	Patent has lapsed	Ref document number: 8502525-2 Format of ref document f/p: F

Date

Code

Title

Description

1995-01-31

NAL

Patent in force

Ref document number: 8502525-2

Format of ref document f/p: F

2001-01-22

NUG

Patent has lapsed